Advanced Gene Vaccines along with the Rising Cases of Virus-based Diseases. FMI Taps an average CAGR
The vaccine market is likely to thrive at a CAGR of 6.6% between 2023 and 2033. The market is anticipated to cross a market valuation of US$ 80.8 billion by 2033 while it is expected to be valued at US$ 42.7 billion in 2023.Expanding healthcare budget for public welfare schemes along with increasing vaccine shots fo...